Artiva Biotherapeutics
James Park is the CEO nominee of GC Cell. He has extensive experience developing biologics, business development, CMC and manufacturing operations, and people management. He has held a variety of leadership positions at several leading multinational biopharmaceutical companies, including Bristol Myers Squibb and Merck. Most recently, Mr. Park served as the EVP and Chief Business Officer of Samsung Biologics.
Mr. Park holds a master’s degree in Management Engineering from Columbia and received his bachelor's degree in chemical engineering from the University of California, Davis.
This person is not in the org chart
This person is not in any offices
Artiva Biotherapeutics
1 followers
Artiva Biotherapeutics is advancing NK cell therapy and CAR-NK therapy for cancer, including blood cancers and solid tumors.